Manufacturer says patients will be able to get the drug privately from September under EU licence

The first ever drug specifically designed to prevent a migraine has been given the green light by European health officials.

Erenumab is now expected to be considered by English and Scottish health agencies to assess whether it is appropriate for NHS use.

Continue reading…

Read More First ever pill to prevent chronic migraines approved by EU

Facebook Comments